Can lorazepam (Ativan) be given to a newborn baby experiencing convulsions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lorazepam Administration in Newborns with Convulsions

Lorazepam can be given to newborns for seizures, but it is contraindicated in premature infants due to benzyl alcohol content in the formulation, and phenobarbital remains the preferred first-line anticonvulsant for neonatal seizures. 1, 2

Critical FDA Contraindication

  • The FDA explicitly contraindicates lorazepam injection in premature infants because the formulation contains benzyl alcohol, which can cause fatal "gasping syndrome" in this population 2
  • For full-term newborns, lorazepam can be used but only with extreme caution and appropriate monitoring 2

First-Line Treatment Hierarchy

  • Phenobarbital (10 mg/kg IV) is the preferred first-line anticonvulsant for neonatal seizures, not lorazepam 1
  • Lorazepam should be reserved for refractory seizures that fail to respond to phenobarbital 3, 4
  • The American Academy of Pediatrics recommends that pharmacologic therapy for withdrawal-associated seizures is indicated, but other causes must be evaluated first 5

When Lorazepam May Be Used in Term Neonates

If phenobarbital fails (typically after 40 mg/kg), lorazepam 0.05 mg/kg IV may be administered, repeatable up to a total dose of 0.15 mg/kg 3

  • In a prospective study of 7 neonates with refractory seizures, 6 of 7 (86%) achieved complete seizure cessation within 3 minutes of lorazepam administration after phenobarbital failure 3
  • Another pilot study showed immediate cessation of seizure activity in all 7 neonatal patients within 5 minutes 4
  • The standard pediatric dose of 0.05-0.10 mg/kg (maximum 4 mg) applies to older infants and children, but neonatal dosing is lower at 0.05 mg/kg per dose 6, 3

Mandatory Safety Precautions

Respiratory support equipment must be immediately available, with continuous oxygen saturation monitoring and unobstructed airway maintenance 1, 6

  • Personnel skilled in airway management must be present before administration 1
  • The risk of apnea increases significantly when lorazepam is combined with other sedatives (including phenobarbital) 1, 6, 7
  • Close monitoring for myoclonus and paradoxical seizure activity is imperative in neonates 7
  • Blood pressure monitoring is essential as hypotension can occur 7

Common Pitfalls to Avoid

  • Never use lorazepam in premature infants under any circumstances due to benzyl alcohol toxicity 2
  • Do not use lorazepam as first-line therapy—phenobarbital must be tried first 1, 3
  • Lorazepam provides no analgesia; do not assume sedation equals pain control 7
  • Seizures often recur within 12-16 hours after lorazepam; be prepared with long-acting anticonvulsants 3
  • The oral route is never appropriate for acute seizure management in neonates 6

Clinical Context for Tolerance-Related Withdrawal

  • For neonates in ICUs who developed tolerance to benzodiazepines from prolonged treatment, they can be converted to oral lorazepam for weaning (distinct from acute seizure management) 5
  • This represents a different clinical scenario than acute convulsion treatment 5

References

Guideline

Lorazepam Administration in Neonates

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Lorazepam in the treatment of refractory neonatal seizures.

Journal of child neurology, 1991

Research

Lorazepam in the treatment of refractory neonatal seizures. A pilot study.

American journal of diseases of children (1960), 1986

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Seizure Management with Lorazepam

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Lorazepam.

Neonatal network : NN, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.